振东制药股价异动 周内上涨超40%;康方生物明星药物冲刺非小细胞肺癌第三项适应证 | 掘金创新药

每日经济新闻
27 Jul

资本眼IPO观察:劲方医药再次冲击港交所上市近日,劲方医药科技(上海)股份有限公司又一次向港交所发起冲刺。这是继今年1月首次递表后的重新提交,前次招股书已失效。创始人吕强与兰炯,一位是北大毕业、留美深造,曾在诺华和基石药业担任高管;另一位是兰州大学博士、有恒瑞和扬子江工作背景的研发干将。他们于2017年携手创立劲方医药,专注于肿瘤、自体免疫和炎症性疾病领域的创新药物开发。招股书(申报稿)显示,劲方...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10